Persistence, Adherence, and Switch Rates Among Extended-Release and Immediate-Release Overactive Bladder Medications in a Regional Managed Care Plan

BACKGROUND: Pharmacotherapy constitutes an important adjunct to behavioral therapy for the treatment of overactive bladder (OAB). Tolterodine and oxybutynin are commonly prescribed drugs for OAB treatment that exert their beneficial effect by suppressing bladder muscle contractions. However, high di...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Souza, Anna O., Smith, Michael J., Miller, Lesley-Ann, Doyle, Joseph, Ariely, Rinat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438114/
https://www.ncbi.nlm.nih.gov/pubmed/18439051
http://dx.doi.org/10.18553/jmcp.2008.14.3.291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438114/
https://www.ncbi.nlm.nih.gov/pubmed/18439051
http://dx.doi.org/10.18553/jmcp.2008.14.3.291

Ejemplares similares